News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
260,408 Results
Type
Article (13556)
Company Profile (110)
Press Release (246742)
Section
Business (87929)
Career Advice (461)
Deals (15324)
Drug Delivery (63)
Drug Development (36521)
Employer Resources (49)
FDA (6259)
Job Trends (6182)
News (150000)
Policy (14004)
Tag
Academia (435)
Alliances (23071)
Alzheimer's disease (345)
Approvals (6248)
Artificial intelligence (55)
Bankruptcy (143)
Best Places to Work (4295)
Biosimilars (37)
Biotechnology (44)
Breast cancer (36)
Cancer (272)
Career advice (404)
Cell therapy (37)
Clinical research (30288)
Collaboration (121)
Compensation (51)
COVID-19 (746)
C-suite (38)
Data (261)
Diabetes (45)
Diagnostics (1228)
Drug pricing (55)
Earnings (31303)
Employer resources (43)
Events (36557)
Executive appointments (138)
FDA (6416)
Funding (86)
Gene therapy (57)
GLP-1 (284)
Government (1261)
Healthcare (3516)
Infectious disease (762)
Inflammatory bowel disease (45)
Interviews (58)
IPO (5804)
Job creations (2048)
Job search strategy (372)
Layoffs (166)
Legal (3406)
Lung cancer (42)
Manufacturing (81)
Medical device (1259)
Medtech (1261)
Mergers & acquisitions (9524)
Metabolic disorders (147)
Neuroscience (433)
NextGen Class of 2024 (1580)
Non-profit (589)
Northern California (362)
Obesity (92)
Opinion (108)
Patents (50)
People (28382)
Pharmaceutical (64)
Phase I (7875)
Phase II (12807)
Phase III (11513)
Pipeline (87)
Podcasts (38)
Policy (42)
Postmarket research (1399)
Preclinical (3155)
Radiopharmaceuticals (116)
Rare diseases (75)
Real estate (2629)
Regulatory (9793)
Research institute (562)
Resumes & cover letters (55)
Southern California (367)
Startups (1624)
United States (3641)
Vaccines (106)
Weight loss (74)
Date
Last 7 days (262)
Last 30 days (911)
Last 365 days (12732)
2024 (10763)
2023 (14244)
2022 (19556)
2021 (20068)
2020 (19033)
2019 (14887)
2018 (11713)
2017 (13890)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10594)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (312)
Arizona (38)
Asia (19737)
Australia (2550)
California (838)
Canada (546)
China (95)
Connecticut (35)
Europe (38656)
Florida (118)
Illinois (95)
Indiana (77)
Kansas (50)
Maryland (135)
Massachusetts (737)
Minnesota (47)
New Jersey (357)
New York (240)
North Carolina (262)
Northern California (362)
Ohio (35)
Pennsylvania (248)
South America (498)
Southern California (367)
Texas (110)
Washington State (63)
260,408 Results for "conatus pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Fennec Pharmaceuticals Announces Management Change
Fennec Pharmaceuticals Inc., a commercial stage specialty pharmaceutical company, announced that Adrian Haigh has departed from his position as Fennec’s Chief Operating Officer as of June 30, 2024.
July 1, 2024
·
4 min read
Deals
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
Deciphera Pharmaceuticals, Inc. today announced that it has entered into a definitive merger agreement with ONO Pharmaceutical Co., Ltd.
April 29, 2024
·
10 min read
Press Releases
Bora Pharmaceuticals to Expand Rare Disease Portfolio with Acquisition of US-Based Pyros Pharmaceuticals
October 28, 2024
·
9 min read
Business
Conatus Pharmaceuticals Appoints Kathy Scott as Independent Board Member
Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) today announced the appointment of Kathleen D. Scott to the Conatus Board of Directors as an additional independent member.
November 18, 2019
·
1 min read
BioMidwest
Aurorium Launches Haelium™ Pharmaceutical Solutions
Aurorium, a specialty ingredients manufacturer and materials innovation partner, is pleased to announce the launch of Haelium™ Pharmaceutical Solutions.
June 25, 2024
·
2 min read
Press Releases
EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock
October 29, 2024
·
7 min read
Press Releases
Acella Pharmaceuticals, LLC, an Alora Pharmaceuticals, LLC Subsidiary, Partners with Paloma Health for Hypothyroidism Patients
October 23, 2024
·
2 min read
Deals
Leading Independent Proxy Advisory Firms Recommend Conatus Pharmaceuticals Shareholders Vote in Favor of its Merger with Histogen and the Required Reverse Stock Split
Conatus Pharmaceuticals Inc. announced that Institutional Shareholder Services Inc. and Glass Lewis, have recommended that Conatus stockholders vote “FOR” Conatus’ proposed merger with Histogen Inc. and “FOR” Conatus’ proposed reverse stock split, both of which are to be considered at Conatus’ upcoming special meeting of stockholders to be held on May 21, 2020.
May 18, 2020
·
7 min read
Deals
Conatus Pharmaceuticals and Histogen Enter into Definitive Merger Agreement
Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) and Histogen Inc., a privately-held regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body, today announced the companies have entered into a definitive agreement under which Histogen will merge with a wholly-owned subsidiary of Conatus in an all-stock transaction.
January 28, 2020
·
11 min read
Deals
Histogen Announces Successful Completion of its Merger with Conatus Pharmaceuticals
Histogen Inc., a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body, announced the completion of its previously disclosed merger with Conatus Pharmaceuticals Inc.
May 27, 2020
·
5 min read
1 of 26,041
Next